Dilvas

✅ Enhances Heart Health
✅ Boosts Immune System
✅ Promotes Bone Strength
✅ Supports Digestive Health
✅ Improves Skin Condition

Dilvas contains Elanapril

Dilvas Tablet is classified as an angiotensin-converting enzyme (ACE) inhibitor medication. It’s primarily prescribed for managing hypertension (high blood pressure) and heart failure, and may be recommended following a heart attack. This medication also helps reduce the risk of future cardiovascular events like heart attacks and strokes.

Dilvas Tablet can be administered as monotherapy or combined with other medications. For optimal absorption, it should be taken on an empty stomach. Consistent daily dosing at the same time is recommended to maintain therapeutic effectiveness. Patients should continue treatment even when asymptomatic or after achieving blood pressure control, as discontinuation may worsen the condition. While generally well-tolerated for chronic use, this medication requires ongoing medical supervision.

Complementary lifestyle modifications can enhance treatment efficacy, including: regular physical activity, weight management, smoking cessation, moderated alcohol consumption, and sodium restriction as directed by your physician. Common adverse effects may include hypotension, persistent cough, hyperkalemia, fatigue, generalized weakness, and dizziness – typically transient in nature. Consult your healthcare provider if side effects persist or cause concern.

Prior to initiating therapy, disclose any renal or hepatic impairment. Pregnancy and breastfeeding require special consideration and medical consultation. Regular monitoring of renal function, blood pressure, and serum potassium levels is recommended during treatment.

THERAPEUTIC INDICATIONS

  • Management of essential hypertension
  • Secondary prevention of cardiovascular events (myocardial infarction and stroke)
  • Chronic heart failure therapy

CLINICAL BENEFITS

Antihypertensive Action

As an ACE inhibitor, Dilvas Tablet exerts its therapeutic effect by decreasing peripheral vascular resistance through vasodilation. This hemodynamic modification reduces cardiac workload and improves circulatory efficiency, resulting in sustained blood pressure reduction. Consistent antihypertensive therapy significantly lowers the incidence of target organ damage, cerebrovascular accidents, and renal complications. The full therapeutic benefit develops gradually, emphasizing the importance of adherence to prescribed regimens despite the absence of immediate symptomatic relief.
ADVERSE EFFECT PROFILE
Most adverse reactions are self-limiting and diminish with continued therapy as physiological adaptation occurs. Medical consultation is advised for persistent or concerning symptoms.

Frequently Reported Adverse Reactions

  • Postural hypotension
  • ACE inhibitor-associated cough
  • Asymptomatic hyperkalemia
  • Asthenia
  • General malaise
  • Vertigo

ADMINISTRATION GUIDELINES

Administer orally as directed by your healthcare provider. The tablet should be swallowed intact without chewing, crushing, or dividing. While food does not significantly affect bioavailability, maintaining consistent administration timing promotes therapeutic stability.

PHARMACOLOGICAL MECHANISM

Dilvas Tablet exerts its pharmacodynamic effects through competitive inhibition of angiotensin-converting enzyme. This blockade prevents the conversion of angiotensin I to angiotensin II, resulting in decreased vasoconstriction and reduced aldosterone secretion. The resultant hemodynamic changes include decreased peripheral vascular resistance and improved cardiac output without reflex tachycardia.

Medical Disclaimer:

This content is provided for educational purposes only and represents curated medical information that has undergone expert review. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. The presented information may not encompass all potential adverse effects, contraindications, or drug interactions. Healthcare decisions should always be made in consultation with a qualified medical professional. This material aims to facilitate informed patient-provider discussions, not to replace clinical judgment or the physician-patient relationship.
Strength

2.5 mg, 5 mg, 10 mg

Quantity

30 Tablet/s, 60 Tablet/s, 90 Tablet/s

Pharma Form

Tablet/s

Manufacturer

Cipla Inc

Treatment

High blood pressure, Heart failure

Generic Brand

Enalapril

Reviews

There are no reviews yet

Add a review
Dilvas Dilvas
Rating*
0/5
* Rating is required
* Answer is required
Your review
* Review is required
Name
* Name is required
Add photos or video to your review
* Please confirm that you are not a robot